eGnome has signed a technology transfer agreement with an international hospital, focusing on cancer gene testing. The partnership aims to expand eGnome's diagnostic capabilities, contributing to advancements in cancer diagnosis and treatment. This agreement highlights eGnome's commitment to leveraging its technology for improving cancer care.